cardiovascular health
The ARTIS Ventures-led raise brings Eko's total raise to $27.8 million.
The Belgium-based company's app can render heart rhythm irregularity readings in roughly 60 seconds.
The startup is looking to buff up its sales teams with the Series B funding.
The daily-use digital intervention yielded "clinically meaningful" improvement in blood pressure among 172 users.
Researchers have now called for the device to be incorporated into standard care in A&E departments.
In addition, Apple shared some snippets of the validation data it shared with the FDA.
Endotronix lands $45 million to launch its Cordella Heart Failure System and further development of its Cordella Pulmonary Artery Sensory system.